[Other] Iberdomide plus daratumumab and dexamethasone versus daratumumab, bortezomib, and dexamethasone in patients with relapsed or refractory multiple myeloma (EXCALIBER-RRMM): an open-label, randomised, controlled, phase 3 trial |
|
This post will be closed automatically in 2026-09-29 15:58
Reward40points
|
20
Thoracolumbar Fractures: An Overview With Emphasis on the Burst Injury
50
[Full book]Electronic Devices & Circuits By Sanjeev Gupta
20
Laboratory Evaluation of Self-Healing Capability of Warm-Mix Asphalt Containing Calcium Alginate Capsules under Aging Conditions
20
Writing an ※A§ Paper in the Age of GenAI: A Guide to Responsible Augmentation
20
Signatures of Decision-Making: Keller and Der gr邦ne Heinrich (1854/55; 1879/80)
